Literature DB >> 21074617

Purification process development of a recombinant monoclonal antibody expressed in glycoengineered Pichia pastoris.

Youwei Jiang1, Fang Li, Dongxing Zha, Thomas I Potgieter, Teresa Mitchell, Renée Moore, Michael Cukan, Nga Rewa Houston-Cummings, Adam Nylen, James E Drummond, Troy W McKelvey, Marc d'Anjou, Terrance A Stadheim, Natarajan Sethuraman, Huijuan Li.   

Abstract

A robust and scalable purification process was developed to quickly generate antibody of high purity and sufficient quantity from glycoengineered Pichia pastoris fermentation. Protein A affinity chromatography was used to capture the antibody from fermentation supernatant. A pH gradient elution was applied to the Protein A column to prevent antibody precipitation at low pH. Antibody from Protein A chromatography contained some product related impurities, which were the misassembling of cleaved heavy chain, heavy chain and light chain. It also had some process related impurities, including Protein A residues, endotoxin, host cell DNA and proteins. Cation exchange chromatography with optimal NaCl gradient at pH 4.5-6.0 efficiently removed these product and process related impurities. The antibody from glycoengineered P. pastoris was comparable to its commercial counterpart in heterotetramer folding, physical stability and binding affinity.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074617     DOI: 10.1016/j.pep.2010.11.004

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  8 in total

1.  Inactivation of a GAL4-like transcription factor improves cell fitness and product yield in glycoengineered Pichia pastoris strains.

Authors:  Bo Jiang; Rebecca Argyros; John Bukowski; Stephanie Nelson; Nathan Sharkey; Sehoon Kim; Victoria Copeland; Robert C Davidson; Ronghua Chen; Jun Zhuang; Natarajan Sethuraman; Terrance A Stadheim
Journal:  Appl Environ Microbiol       Date:  2014-10-24       Impact factor: 4.792

2.  Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study.

Authors:  Ningyan Zhang; Liming Liu; Calin Dan Dumitru; Nga Rewa Houston Cummings; Michael Cukan; Youwei Jiang; Yuan Li; Fang Li; Teresa Mitchell; Muralidhar R Mallem; Yangsi Ou; Rohan N Patel; Kim Vo; Hui Wang; Irina Burnina; Byung-Kwon Choi; Hans E Huber; Terrance A Stadheim; Dongxing Zha
Journal:  MAbs       Date:  2011-05-01       Impact factor: 5.857

Review 3.  Biochemical and biophysical characterization of humanized IgG1 produced in Pichia pastoris.

Authors:  Sha Ha; Yang Wang; Richard R Rustandi
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

4.  Expression of functional eGFP-fused antigen-binding fragment of ranibizumab in Pichia pastoris.

Authors:  Shirin Movaghar Asareh; Tahereh Savei; Sareh Arjmand; Seyed Omid Ranaei Siadat; Fataneh Fatemi; Mehrab Pourmadadi; Javad Shabani Shayeh
Journal:  Bioimpacts       Date:  2021-10-11

5.  A human single-domain antibody elicits potent antitumor activity by targeting an epitope in mesothelin close to the cancer cell surface.

Authors:  Zhewei Tang; Mingqian Feng; Wei Gao; Yen Phung; Weizao Chen; Amit Chaudhary; Brad St Croix; Min Qian; Dimiter S Dimitrov; Mitchell Ho
Journal:  Mol Cancer Ther       Date:  2013-01-31       Impact factor: 6.261

6.  Generation of diploid Pichia pastoris strains by mating and their application for recombinant protein production.

Authors:  Ming-Tang Chen; Song Lin; Ishaan Shandil; Dewan Andrews; Terrance A Stadheim; Byung-Kwon Choi
Journal:  Microb Cell Fact       Date:  2012-07-02       Impact factor: 5.328

7.  A dual-mode surface display system for the maturation and production of monoclonal antibodies in glyco-engineered Pichia pastoris.

Authors:  Hussam H Shaheen; Bianka Prinz; Ming-Tang Chen; Tej Pavoor; Song Lin; Nga Rewa Houston-Cummings; Renee Moore; Terrance A Stadheim; Dongxing Zha
Journal:  PLoS One       Date:  2013-07-10       Impact factor: 3.240

8.  A collagen-binding EGFR antibody fragment targeting tumors with a collagen-rich extracellular matrix.

Authors:  Hui Liang; Xiaoran Li; Bin Wang; Bing Chen; Yannan Zhao; Jie Sun; Yan Zhuang; Jiajia Shi; He Shen; Zhijun Zhang; Jianwu Dai
Journal:  Sci Rep       Date:  2016-02-17       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.